ALPS GROUP INC

AI-generated fair value estimate for this company.

Method: Deep out-of-the-money option cross-check anchored to observed market price: ALPS Group Inc common trades at $0.3999 (9/17/2026) versus the warrant's $11.50 strike (~4 years remaining to ~October 2030 expiration); spot/strike ratio of ~3.5% is far out-of-the-money; a naive Black-Scholes estimate even at extreme 100-150% volatility implies $0.05-0.22, but that ignores the severe dilution and going-concern risk evidenced by ALPS's ~97% 52-week price collapse (from $15.00 to $0.23-0.40) and the warrant's near-zero actual liquidity, so the estimate is anchored to the observed $0.0035 market price

Reasoning: ALPS Group is a micro-cap, loss-making, heavily-diluted post-SPAC biotech, so the warrant's real economic value is negligible; using the actual thinly-traded market price as the grounded estimate is more honest than a textbook option model that ignores dilution and going-concern risk.